| 标题 |
专利、报告等 Final results and subgroup analysis of ORIENTAL: A phase IIIB study of durvalumab plus platinum-etoposide in first-line treatment of Chinese patients with extensive-stage small-cell lung cancer(ES-SCLC)
|
| 备注 |
2023 ESMO Asia大会海报
💡 该求助存在备注,如果存在信息冲突,请以备注为准
|
| 网址 | |
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)